液相色谱分析AEE788对映体纯度

在Chiralcel OD-H色谱柱上,采用正己烷与异丙醇或乙醇为流动相,对AEE788对映体进行了拆分,考察了流动相组成、柱温和流速等条件对拆分效果的影响。结果表明,AEE788对映体在正己烷-异丙醇-二乙胺(75:25:0.15,V/V/V)为流动相、柱温25℃、流速1.0 mL/min条件下,分离度为1.85,分析时间小于12 min。该分析方法的建立对药物AEE788不对称反应研究、分析/分离方法的开发及其生产过程的质量监控都具有非常重要的意义。     

9-蒽醛衍生化-高效液相色谱法拆分α-氨基酸甲酯和几种脂肪胺对映体

采用高效液相色谱法,以9-蒽醛为衍生试剂,在5种多糖衍生物的手性固定相(CSPs)上对几种α-氨基酸甲酯对映体进行了手性分离。色谱条件如下: 流动相为含3%～10%(v/v)异丙醇的正己烷溶液,流速为1.0 mL/min,检测波长为254 nm。结果表明,α-氨基酸甲酯-9-蒽醛亚胺衍生物在Chiralcel OD柱或Chiralcel OD-H柱上的手性分离结果优于其他CSPs,而且在Chiralcel OD柱或Chiralcel OD-H柱上全部得到了基线拆分(α=1.24～5.47, Rs=2.56～13.90), L-对映体在这两种色谱柱上的保留强于D-对映体。同时还考察了几种脂肪胺在5种多糖衍生物手性固定相上的对映体拆分效果,结果表明脂肪胺的9-蒽醛亚胺衍生物在Chiralcel OD柱或Chiralcel OD-H柱上的分离效果良好。该法可用于其他α-氨基酸酯和胺类化合物对映体的分析。     

柱前衍生高效液相色谱法测定NTCA的光学纯度

用1-萘胺对乙酰四氢噻唑-2-硫酮-4-羧酸进行柱前衍生,产生非对映体衍生物.以正己烷和乙醇或异丙醇为流动相,选择Chiralcel OD-H色谱柱上对NTCA衍生物进行了拆分,考察了流动相组成和柱温对其衍生物分离的影响,获得较好的分析条件,分离因子达到1.3.该结果进一步与旋光仪法相比较,相对偏差不超过1.9%.     

高效液相色谱使用两种类型的纤维素-三(对甲基苯甲酸酯)固定相手性拆分非洛地平的比较

以高效液相色谱手性固定相法对非洛地平(FEL)进行手性拆分。分别采用两种类型的纤维素-三(对甲基苯甲酸酯)手性柱Chiralcel OJ-R和Chiralcel OJ-H进行比较实验,以正己烷-异丙醇(90:10, v/v)为流动相,考察了流动相、柱温对保留及手性拆分的影响。实验显示,两柱拆分FEL的van’t Hoff图均发生了转折,在高温区域为焓驱动,在低温区域为熵驱动。两柱在温度升高时拆分FEL的分离度均提高,其中OJ-H的分离度优于OJ-R。两种手性柱对FEL具有相似的拆分机理。     

Chiralpak AD和Chiralcel OD-H手性固定相拆分3α-酰氧基-6β-乙酰氧基莨菪烷类化合物

采用高效液相色谱法,以不同配比的正己烷-异丙醇为流动相,在正相色谱条件下,考察了6个3α-酰氧基-6β-乙酰氧基莨菪烷对映体在淀粉型手性固定相Chiralpak AD、纤维素型手性固定相Chiralcel OD-H上的分离情况,以建立该类化合物的手性拆分方法。结果表明,在Chiralpak AD手性柱上,对映体6实现完全分离,而对映体1完全不能分离;在Chiralcel OD-H柱上,对映体1、4、3分别实现完全分离、基线分离和基本分离,对映体6只能实现部分分离;对映体5在两种手性柱上都完全不能被分离。说明固定相手性空腔的结构对化合物的拆分结果影响很大。研究发现,C-3α位取代基团的空间位阻效应主导手性固定相对对映体的选择性识别作用,而化合物与固定相之间的分子间作用力对手性拆分也产生重要影响。研究结果为其他莨菪烷类化合物的手性拆分提供了参考。     

高效液相手性固定相法拆分1-苯乙烯基-3-己基丙炔醇

以纤维素衍生物为手性固定相,建立药物中间体1-苯乙烯基-3-己基丙炔醇对映体的HPLC手性分析方法。以正己烷与乙醇或异丙醇为流动相,在Chiralcel OD-H手性固定相上对1-苯乙烯基-3-己基丙炔醇进行了拆分,并考察了流动相组成、流速和柱温对该对映体分离的影响,获得较优分析条件,分析时间在15 min内,分离度大于1.5。结果表明,1-苯乙烯基-3-己基丙炔醇对映体在正己烷-异丙醇(体积比90:10)为流动相、流速为1.0 m L/min、柱温为25℃时,分离效果最佳。本方法可用于1-苯乙烯基-3-己基丙炔醇对映体的质量控制。     

氟环唑外消旋体在纤维素-三(3,5-二甲基苯基氨基甲酸酯)手性固定相上的高效液相色谱法拆分

在纤维素-三(3,5-二甲基苯基氨基甲酸酯)（CDMPC）手性固定相上,分别采用正相、反相及极性有机相色谱模式对氟环唑外消旋体进行了拆分,并考察了流动相组成在手性识别中对手性分离的影响。氟环唑在Chiralcel OD-H手性色谱柱（填充CDMPC手性固定相）上采用反相色谱模式,以甲醇-水(体积比为80∶20)为流动相,获得了最佳的拆分,其两对对映异构体的分离度Rs分别为1.64和6.50。     

柱前衍生化-HPLC测定仲丁胺对映体的纯度

用3, 5-二硝基苯甲酸对仲丁胺进行柱前衍生, 将其衍生物在CHIRALCEL OD-H手性固定相上拆分, 并通过二极管阵列紫外检测器对其衍生物进行检测, 建立了一种拆分仲丁胺消旋体、测定仲丁胺光学纯度的新方法. 以正己烷和乙醇或异丙醇为流动相, 在CHIRALCEL OD-H手性固定相上对仲丁胺衍生物进行了拆分, 并考察了流动相组成和柱温对该对映体衍生物分离的影响, 获得较好的分析条件, 分离因子大于1.2. 非手性试剂柱前衍生化法测定仲丁胺光学纯度与旋光度方法比较, 结果一致. 方法可用于仲丁胺对映体的质量控制.     

高效液相色谱法手性色谱柱分离3-羟基丁酸乙酯对映体

采用Chiralcel OD-H手性色谱柱(4.6mm×250mm,5μm)作为分离柱,用高效液相色谱法对3-羟基丁酸乙酯对映体进行了拆分。在优化的色谱条件下,正己烷-异丙醇(100+5)溶液为流动相,流量为1.0mL·min-1,柱温为25℃。3-羟基丁酸乙酯对映异构体在11min内成功分离,分离度达4.25。     

茚虫威对映体分离及手性拆分热力学研究

在纤维素-三-(3,5-二甲基苯基氨基甲酸酯)(Chiralcel OD-H)手性柱上对茚虫威对映体的分离进行了研究。考察了流动相中改性剂种类和浓度、流速及柱温对分离效果的影响,并对茚虫威对映体与固定相之间保留和分离的热力学机理进行了讨论。结果表明,以正己烷-异丙醇(85∶15)为流动相,柱温为25℃,流速1.0 mL.min-1时,茚虫威对映体能获得基线分离,分离因子(α)和分离度(Rs)分别为1.50和3.49;分别以5种体积分数均为15%的醇改性正己烷,分离因子的变化顺序为:异丁醇异丙醇乙醇正丁醇正丙醇,正丙醇的分离因子为1.67,证明醇的极性和空间位阻同时影响拆分效果;在0.4~1.1 mL.min-1的流速范围内,分离度(Rs)随着流速的增大而逐渐减小;当柱温为15~35℃时,分离因子随着温度的升高呈降低趋势,两对映体的lnα与1/T呈良好的线性关系,手性拆分过程受焓的控制。     

Direct chromatographic resolution of racemic aminoglutethimide and its acetylated metabolite using different cellulose based chiral stationary phases

Summary Two improved methods for the enantiomeric separation of racemic aminoglutethimide (±AG) and its acetylated metabolite (±AAG) have been developed. Direct liquid chromatographic resolution of the enantiomers of aminoglutethimide and its acetylated metabolite was accomplished using Chiralcel OD and Chiralcel OJ columns without any derivatization. Maximum resolution of 8.87 and 2.23 was obtained for the enantiomers of aminoglutethimide and its acetylated metabolite using a Chiralcel OD column, while maximum resolution of 10.34 and 7.01 was obtained for the enantiomers using a Chiralcel OJ column. Optimization of separation was obtained using different concentration of 2-propanol in hexane as a mobile phase.     

高效液相色谱法拆分硅氟唑对映体

在纤维素-三-(3,5-二甲基苯基氨基甲酸酯)(Chiralcel OD-H)手性柱上对硅氟唑对映体的分离进行了研究.考察了流动相中改性剂的种类和浓度、流速以及柱温对分离效果的影响,并对手性拆分机制进行了讨论.实验结果表明:5种醇改性剂中,异丙醇的改性效果最佳,当异丙醇含量为2%时,分离度(Rs)达最大值10.19;在...     

Enantioselective HPLC resolution of synthetic intermediates of armodafinil and related substances

Armodafinil is a unique psychostimulant recently approved by the US Food and Drug Administration for the treatment of narcolepsy. The chromatographic resolution of its chiral intermediates including related substances in the total synthesis of armodafinil was studied on polysaccharide-based stationary phases, viz. cellulose tris-(3,5-dimethylphenylcarbamate) (Chiralcel OD-H) and amylose tris-(3,5-dimethylphenylcarbamate) (Chiralpak AD-H) by HPLC. The effects of 1-propanol, 2-propanol, ethanol, and trifluoroacetic acid added to the mobile phase and of column temperature on resolution were studied. A good separation was achieved on cellulose-based Chiralcel OD-H column compared to amylose-based Chiralpak AD-H. The effects of structural features of the solutes and solvents on discrimination between the enantiomers were examined. Baseline separation with R(s) >1.38 was obtained using a mobile phase containing n-hexane-ethanol-TFA (75:25:0.15 v/v/v). Detection was carried out at 225 nm with photodiode array detector while identification of enantiomers was accomplished by a polarimetric detector connected in series. The method was found to be suitable not only for process development of armodafinil but also for determination of the enantiomeric purity of bulk drugs and pharmaceuticals.     

几种苯甲酰胺类抗精神病药物的手性色谱拆分及其对映体含量的测定

采用直链淀粉-三(5-氯-2-甲基苯基氨基甲酸酯)手性固定相(CSP),以0.1%二乙胺正己烷和0.1%二乙胺乙醇为流动相梯度洗脱,以舒必利、阿米舒必利和莫沙必利为目标物,利用高效液相色谱法研究了这3种苯甲酰胺类药物的手性色谱分离行为。分别考察了流动相组成、添加剂及柱温对3种药物对映体分离的影响,从热力学和结构上探讨了色谱拆分的机理。结果表明: 在优化的色谱条件下,舒必利、阿米舒必利和莫沙必利对映体的分离度Rs＞1.5;计算了3种药物对映体的色谱保留因子k和分离因子α,以及与CSP相互作用的热力学函数,其相互作用大小依次为舒必利＞阿米舒必利＞莫沙必利。已将该方法成功地应用于上述3种药物片剂和血清中其对映体的测定,方法简便、准确、可靠。     

Direct liquid chromatographic resolution of racemic aminoglutethimide and its acetylated metabolite using a chiral alpha 1-acid glycoprotein column

A 10-cm long alpha 1-acid glycoprotein column is used for the enantiomeric resolution of the clinically used racemic aminoglutethimide (+/- AG) and its acetylated metabolite (+/- AAG). A direct liquid chromatographic resolution of racemic aminoglutethimide and its acetylated metabolite is accomplished without any derivatizations. Maximum resolutions of 1.37 and 0.73 are obtained for the enantiomers of aminoglutethimide and its acetylated metabolite, respectively. The effect of the 2-propanol content in mobile phase on retention and enantioselectivity of aminoglutethimide and its acetylated metabolite is demonstrated. The variation of the separation factors (alpha) with pH in enantiomeric separation of aminoglutethimide is also shown.     

A validated chiral HPLC method for the determination of mebeverine HCl enantiomers in pharmaceutical dosage forms and spiked rat plasma

A new, precise, simple and accurate HPLC method was developed for the first time to separate and determine mebeverine enantiomers. Enantiomeric resolution was achieved on a cellulose Tris (3,5-dimethylphenyl carbamate) column known as Chiralcel OD, with UV detection at 263 nm. The mobile phase consisted of n-hexane, isopropyl alcohol and triethylamine (90:9.9:0.1 v/v/v). Sample run time was 18 min. On using the chromatographic conditions described, mebeverine enantiomers were well resolved with mean retention times of about 11 and 14 min. A linear response (r>0.999) was observed over the concentration range 0.5-20 microg/mL racemic mebeverine. Precision, accuracy and stability were studied according to ICH guidelines. The limit of detection was found to be 0.05 microg/mL for each enantiomer of mebeverine. The proposed method was applied for analysis of mebeverine in commercially available tablets dosage formulations. Examples of application to biological samples are also given. Reanalysis of samples several weeks after the initial analysis showed no degradation of mebeverine.